secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2023-05-19T23:59:59+00:00
Accession:  0001493152-23-018330
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical adopts amended bylaws with universal proxy rules, board expansion requires 75% approval
--------------------------------------------------------------------------------

- Board approved Third Amended and Restated Bylaws effective June 1, 2023, incorporating SEC universal proxy rules and recent DGCL amendments.
- Stockholder nominations and proposals now require additional background information; proxy card color rule adopted (white reserved for Board).
- Board expansion beyond seven members requires approval of at least 75% of directors then in office.
- New emergency bylaw provisions allow greater flexibility during disasters or catastrophes as permitted by DGCL.
- Notice by electronic transmission revised; advance stockholder consent requirement removed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223018330/0001493152-23-018330-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223018330/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-018330

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer